Navigation Links
Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
Date:4/25/2012

ducts domestically and internationally, clinical and regulatory developments (domestic or foreign) involving current and future products, sales growth of recently launched products, competition from other products (domestic or foreign) and difficulties or delays in manufacturing our products.  In addition, sales of our products are affected by reimbursement policies imposed by third-party payers, including governments, private insurance plans and managed care providers and may be affected by regulatory, clinical and guideline developments and domestic and international trends toward managed care and health care cost containment as well as U.S. legislation affecting pharmaceutical pricing and reimbursement.  Government and others' regulations and reimbursement policies may affect the development, usage and pricing of our products.  Furthermore, our research, testing, pricing, marketing and other operations are subject to extensive regulation by domestic and foreign government regulatory authorities.  We, or others, could identify safety, side effects or manufacturing problems with our products after they are on the market.  Our business may be impacted by government investigations, litigation and product liability claims.  Further, while we routinely obtain patents for our products and technology, the protection offered by our patents and patent applications may be challenged, invalidated or circumvented by our competitors.  We depend on third parties for a significant portion of our manufacturing capacity for the supply of certain of our current and future products and limits on supply may constrain sales of certain of our current products and product candidate development.  In addition, we compete with other companies with respect to some of our marketed products as well as for the discovery and development of new products.  Discovery or identification of new product candidates cannot be guaranteed and movement from conc
'/>"/>
SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Amgen Announces Webcast of 2012 First Quarter Financial Results
2. UCB and Amgen Initiate Sclerostin Antibody Phase 3 Program in Patients With Postmenopausal Osteoporosis
3. Amgen Completes Tender Offer for Outstanding Shares of Micromet, Inc.
4. Schwartz Center Receives $500,000 Grant from the Amgen Foundation
5. Amgen to Present at the Cowen and Company 32nd Annual Healthcare Conference
6. Amgen and Micromet Announce Early Termination of HSR Waiting Period for Amgens Acquisition of Micromet
7. Amgens Full Year 2011 Revenue Increased 4 Percent to $15.6 Billion and Adjusted Earnings Per Share (EPS) Increased 2 Percent to $5.33
8. Amgen Announces Final Results of Its Tender Offer
9. Amgen Announces Preliminary Results of Its Tender Offer
10. AMG 277 Discriminates Against S1P3 Receptor by 50-fold. S1P1 Lead Compounds Will Be Offered for Sale at a December 8, 2011 Sealed Bid Sale. Assets Generated by Epix Pharmaceuticals, Inc. and Amgen.
11. Amgen Statement on European Investor Visit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... Columbia, March 26, 2015  OncoGenex Pharmaceuticals, Inc. ... of clinical developments and announced fourth quarter and ... Clinical Developments and Anticipated Near-term MilestonesCustirsen ... agreed to negotiate the termination of their collaboration ... the final termination agreement are ongoing. , ...
(Date:3/26/2015)... , March 26, 2015  CCS Medical ... home medical supplies for patients with chronic conditions, ... and Chief Executive Officer, effective March 23.  Mr. ... telehealth company, where he was President of Operations. ... was President and Executive Vice President of Operations ...
(Date:3/26/2015)... , March 26, 2015 Zimmer Holdings, Inc. ... new mobile app designed to serve as a feature-rich resource ... product. For those experiencing knee pain, the ... about the causes of knee pain and helps them understand ... a safe and simple non-surgical treatment option. For those who ...
Breaking Medicine Technology:OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 2OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 3OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 4OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 5OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 6OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 7OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 8CCS Medical Team Hires Industry Operator Rodney Carson as CEO 2Zimmer Launches New Patient Education And Engagement Mobile App For Gel-One Hyaluronate 2
... VSCP ), a provider of quantitative imaging for clinical ... 30, 2010 exceeded $3.5 million, representing a greater than 25% ... than 9% growth over the preceding quarter ended June 30, ... September 30, 2010 compared to the same period in 2009. ...
... Amex: PTN ) announced that it will be ... October 6, 2010 at 8:00 AM PT.  Hosted by the ... will take place October 5-6 at the Palace Hotel in ... and Chief Executive Officer of Palatin Technologies, will provide an ...
Cached Medicine Technology:VirtualScopics Revenues Hit Another Quarterly Record 2VirtualScopics Revenues Hit Another Quarterly Record 3
(Date:3/26/2015)... CA (PRWEB) March 26, 2015 Dr. ... are proud to announce expanded offerings for Bay Area ... Francisco Dental Implant Center has long been a top-rated ... expanded its offerings to meet the strong demand by ... our reputation as a top-rated dental implant facility in ...
(Date:3/26/2015)... Springs, FL (PRWEB) March 26, 2015 ... of the nation’s leading innovative specialty pharmacies, announces ... created position of Vice President of Pharmaceutical Relations. ... fostering beneficial connections with our pharmaceuticals partners and ... relationships in support of BioPlus’ expansion. , ...
(Date:3/26/2015)... (PRWEB) March 26, 2015 In the key ... as of 2013 and is set to decrease through 2020 ... 2020; the growth is expected up to 2017 at a ... expected to be owing to the surging penetration of fixed-dose ... Twynsta, Micardis Plus, Valturna, Benicar HCT, and Tekamlo), a hike ...
(Date:3/26/2015)... Sunrise, FL (PRWEB) March 26, 2015 ... unveiled its brand-new, state-of-the-art company website: http://www.metabolicnutrition.com ... of the revamped website creates a user-friendly experience ... supplement company. , The new, enhanced Metabolic ... Comprehensive information about the company’s diverse line of ...
(Date:3/26/2015)... Zane Benefits, the leader in individual ... eBook, “The Comprehensive Guide To Interviewing For Your Small ... most important aspect of the hiring process. Many small ... right way, possibly resulting in thousands of dollars lost. ... yet it’s essential to the success of your small ...
Breaking Medicine News(10 mins):Health News:Bay Area Dental Implant Specialist, Dr. Alex Rabinovich Announces Regional Educational Strategy 2Health News:Bay Area Dental Implant Specialist, Dr. Alex Rabinovich Announces Regional Educational Strategy 3Health News:BioPlus Specialty Pharmacy Expands Executive Team with New Position, Naming Sharon Ferrer as Vice President of Pharmaceutical Relations 2Health News:Top 8 Developed Anti-Hypertensive Therapeutics Markets Discussed in New GBI Research Report Published at MarketPublishers.com 2Health News:Top 8 Developed Anti-Hypertensive Therapeutics Markets Discussed in New GBI Research Report Published at MarketPublishers.com 3Health News:Metabolic Nutrition Launches Sleek New Website with New Features and Enhanced Consumer Information 2Health News:Zane Benefits Announces: New eBook: The Comprehensive Guide To Interviewing For Your Small Business 2
... ... ... of complex government regulation some of the stand-out questions include:, , ,   ... How are these standards impacted by the convergence of media and conflation of traditional media ...
... , ... ... ... ...
... ... ... ... ...
... study has confirmed earlier study results that 400 ... efficacy and tolerability for patients with uncontrolled partial-onset ... additional benefit for some patients. Researchers from the ... Center, Thomas Jefferson University Medical School, Arkansas Epilepsy ...
... The maximal standardized uptake value (called SUVmax) measured ... tumor in head and neck squamous cell carcinoma ... disease-specific survival, overall survival and disease-free survival, while ... distant metastasis, according to a study presented at ...
... Natural defense against the disease could be more common than ... The seemingly miraculous recovery from rabies of a 17-year-old Texas ... is leaving doctors scratching their heads and wondering if such ... case "suggests the rare possibility that abortive rabies can occur ...
Cached Medicine News:Health News:Alan Chapell, President of Chapell & Associates to Deliver Keynote at the Next AdMonsters US Leadership Forum 2Health News:Alan Chapell, President of Chapell & Associates to Deliver Keynote at the Next AdMonsters US Leadership Forum 3Health News:Highmark Inc. Prepares Now for the Diversity Boom Ahead 2Health News:Highmark Inc. Prepares Now for the Diversity Boom Ahead 3Health News:Highmark Inc. Prepares Now for the Diversity Boom Ahead 4Health News:Providence Service Corporation to Present at the RBC Capital Markets Healthcare Conference on Tuesday, March 2nd 2Health News:Providence Service Corporation to Present at the RBC Capital Markets Healthcare Conference on Tuesday, March 2nd 3Health News:Providence Service Corporation to Present at the RBC Capital Markets Healthcare Conference on Tuesday, March 2nd 4Health News:Lacosamide validated as promising therapy for uncontrolled partial-onset seizures 2Health News:Lacosamide validated as promising therapy for uncontrolled partial-onset seizures 3Health News:Pretreatment SUV associated with head and neck cancer treatment outcomes, may help decide treatment plans 2Health News:Texas Girl Recovers From Rabies Without Intensive Care 2
... Cochrane Reviews enable all those involved with ... with the very latest evidence in their ... becomes harder each year as the volume ... problem by delivering the best single source ...
Muscles Anatomy Flash Cards uses the time tested content and images from BryanEdwards.com....
Pocket Sports Medicine is the result of a collaboration between outstanding Editors and Contributors. The program covers the field so that both specialists and general orthopedists will find expert g...
... Cochrane Reviews enable all those involved with ... with the very latest evidence in their ... becomes harder each year as the volume ... problem by delivering the best single source ...
Medicine Products: